Literature DB >> 12581187

Distribution and frequency of beta-thalassemia mutations in northwestern and central Greece.

I Georgiou1, A Makis, A Chaidos, I Bouba, E Hatzi, V Kranas, C Zilidis, K L Bourantas.   

Abstract

OBJECTIVES: Beta-Thalassemia is a common autosomal recessive disorder resulting from over 200 different mutations of the beta-globin genes. The spectrum of beta-thalassemia mutations in Greece has been previously described in the population of the capital city of Athens, or in beta-thalassemia patients having transfusion therapy. The aim of the present study was to identify the distribution of the most common beta-thalassemia mutations in the population of northwestern and central Greece.
METHODS: The data for this study were derived from a total of 1,130 unrelated subjects including 46 beta-thalassemia major, three beta -thalassemia intermedia and 1,081 carriers identified in our antenatal screening program. beta-Thalassemia mutations were identified by ARMS, DGGE and Reverse Dot Blot.
RESULTS: The most common mutation, IVS-I-110, is followed, in order of frequency, by the mutations Cd-39, IVS-I-1, IVS-II-1, Cd-6, IVS-I-6, IVS-I-5, IVS-II-745, Cd-5 and 44 bp del. IVS-I-110 and Cd-39 frequencies are similar with those found in other Balkan countries. Significant differences in regional distribution were observed. The results showed a clear drift of the distribution of the most frequent IVS-I-110 mutation in the south-north (29.4, 40.0, 44.6 and 61.7%) and the east-west axis (31.8 and 44.6%).
CONCLUSIONS: Population screening and prenatal diagnosis are significantly facilitated by these data. Furthermore, the detailed distribution tables of beta-thalassemia mutations are essential for counseling and extraction of genetic diversity estimates for population genetic studies in other inherited disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581187     DOI: 10.1034/j.1600-0609.2003.00017.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  7 in total

1.  A search for β thalassemia mutations in 4000 year old ancient DNAs of Minoan Cretans.

Authors:  Jeffery R Hughey; Meijun Du; Qiliang Li; Manolis Michalodimitrakis; George Stamatoyannopoulos
Journal:  Blood Cells Mol Dis       Date:  2011-10-14       Impact factor: 3.039

Review 2.  PCR-SSCP: a method for the molecular analysis of genetic diseases.

Authors:  V Konstantinos Kakavas; Kakavas V Konstantinos; Panagiotis Plageras; Plageras Panagiotis; T Antonios Vlachos; Vlachos T Antonios; Agelos Papaioannou; Papaioannou Agelos; V Argiris Noulas; Noulas V Argiris
Journal:  Mol Biotechnol       Date:  2007-10-13       Impact factor: 2.695

3.  Biochemical and molecular analysis of the beta-globin gene and LCR region on Saudi β-thalassemia patients.

Authors:  Hayat Alafari; Faris Q Alenzi
Journal:  Saudi J Biol Sci       Date:  2020-09-04       Impact factor: 4.219

4.  Identification of the four most common beta-globin gene mutations in Greek beta-thalassemic patients and carriers by PCR-SSCP: advantages and limitations of the method.

Authors:  Konstantinos V Kakavas; Argiris Noulas; Christos Chalkias; Christos Hadjichristodoulou; Ioannis Georgiou; Elena Georgatsou; Sophia Bonanou
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  Recommendations for genetic variation data capture in developing countries to ensure a comprehensive worldwide data collection.

Authors:  George P Patrinos; Jumana Al Aama; Aida Al Aqeel; Fahd Al-Mulla; Joseph Borg; Andrew Devereux; Alex E Felice; Finlay Macrae; Makia J Marafie; Michael B Petersen; Ming Qi; Rajkumar S Ramesar; Joel Zlotogora; Richard G H Cotton
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

6.  Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine.

Authors:  Rashail Faraon; Mahmoud Daraghmah; Fekri Samarah; Mahmoud A Srour
Journal:  BMC Hematol       Date:  2019-02-18

7.  β-Thalassemia mutations and hemoglobinopathies in Adana, Turkey: results from a single center study.

Authors:  Birol Guvenc; Abdullah Canataroglu; Cagatay Unsal; Sule Menziletoglu Yildiz; Ferda Tekin Turhan; Sevcan Tug Bozdogan; Suleyman Dincer; Hakan Erkman
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.